OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex molecules. Enhancing these processes involves fine-tuning various factors, including cell line selection, media formulation, and bioreactor settings. A key goal is to maximize antibody titer while reducing production financial b